(Q53724145)

18 May 2018

title

Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice. (English)

1 reference

18 May 2018

author name string

Murakami H

1

1 reference

18 May 2018

Takahagi Y

2

1 reference

18 May 2018

Yoshitatsu M

3

1 reference

18 May 2018

Miyagawa S

4

1 reference

18 May 2018

Fujimura T

5

1 reference

18 May 2018

Toyomura K

6

1 reference

18 May 2018

Shigehisa T

7

1 reference

18 May 2018

Shirakura R

8

1 reference

18 May 2018

Kinoshita T

9

1 reference

18 May 2018

publication date

1 April 2000

1 reference

18 May 2018

published in

Immunobiology

1 reference

18 May 2018

volume

201

1 reference

18 May 2018

issue

5

1 reference

18 May 2018

page(s)

583-597

1 reference

18 May 2018

The mechanism of discordant xenograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Direct activation of porcine endothelial cells by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Reduction of the major swine xenoantigen Gal alpha (1,3)Gal by transfection of N-acetylglucosaminyl transferase III (GnT-III) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Characterization of pigs transgenic for human decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Molecular cloning of a pig homologue of membrane cofactor protein (CD46).

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

Position-independent, high-level expression of the human beta-globin gene in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980076-5

7 January 2021

10.1016/S0171-2985(00)80076-5

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018